Revenue: As of FY2026 Q1, the actual value is USD 11.71 M, beating the estimate of USD 9.826 M.EPS: As of FY2026 Q1, the actual value is USD -0.71, missing the estimate of USD -0.69.EBIT: As of FY2026 Q1, the actual value is USD -31.4 M.Senseonics Holdings, Inc. issued a press release on May 7, 2026, announcing its financial results for the quarter ended March 31, 2026, and providing corporate highlights and outlook. <h4>Revenue</h4>Senseonics Holdings, Inc. generated total revenue of $11.7 million in Q1 2026, an 87% increase year-over-year compared to $6.3 million in Q1 2025. U.S. revenue for Q1 2026 was $9.3 million, an increase from $4.5 million in Q1 2025. Revenue outside the U.S. was $2.4 million in Q1 2026, compared to $1.8 million in the prior year period. <h4>Gross Profit and Margin</h4>Gross profit for Q1 2026 was $6.9 million, significantly up from $1.5 million in Q1 2025. The company achieved a gross margin of 59% in Q1 2026, representing a 35% increase year-over-year. Q1 2026 gross profit included a one-time benefit of $0.5 million related to the timing of the Eversense 365 product launch in Europe. <h4>Operating Expenses</h4>Research and Development (R&amp;D) expenses increased by $1.3 million year-over-year to $8.6 million in Q1 2026 from $7.3 million in Q1 2025. Selling, General and Administrative (SG&amp;A) expenses increased by $22.5 million year-over-year to $30.2 million in Q1 2026 from $7.7 million in Q1 2025. Operating loss was - $31.846 million in Q1 2026 compared to - $13.488 million in Q1 2025. <h4>Net Loss</h4>Senseonics Holdings, Inc. reported a net loss of - $32.3 million in Q1 2026, compared to a net loss of - $14.3 million in Q1 2025. Basic net loss per common share was - $0.71 in Q1 2026, compared to - $0.40 in Q1 2025. Diluted net loss per common share was - $0.71 in Q1 2026, compared to - $0.40 in Q1 2025. <h4>Other Financials</h4>Interest income was $742 thousand in Q1 2026, compared to $675 thousand in Q1 2025. Interest expense was - $1.192 million in Q1 2026, compared to - $1.429 million in Q1 2025. Other expense was - $37 thousand in Q1 2026, compared to - $17 thousand in Q1 2025. Total other income (expense), net was - $487 thousand in Q1 2026, compared to - $771 thousand in Q1 2025. Total comprehensive loss was - $32.394 million in Q1 2026, compared to - $14.262 million in Q1 2025. <h4>Balance Sheet Highlights (as of March 31, 2026)</h4>Cash, cash equivalents and investments totaled $64.6 million. Outstanding indebtedness was $35.2 million. Cash and cash equivalents were $29.612 million. Short term investments, net were $34.709 million. Total assets were $102.857 million. Total liabilities were $68.522 million. Total stockholders’ equity was $34.335 million. <h4>Operational Metrics</h4>Direct-to-consumer (DTC) new patient adds were up nearly 100% year-over-year. Senseonics Holdings, Inc. raised $92 million in growth capital through a recent public offering of securities and over $100 million in total equity and debt financing. <h4>Outlook / Guidance</h4>Senseonics Holdings, Inc. now expects full-year 2026 global net revenue to be approximately $60 – $64 million, an increase from the previously projected range of $58M to $62M. This represents year-over-year growth of 70% – 82%. Gross margins are anticipated to be approximately 55% – 58% for the full year.

Senseonics | 8-K: FY2026 Q1 Revenue Beats Estimate at USD 11.71 M